Diabetes Kongress 2019
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. Stefan Kaspers
Boehringer Ingelheim International GmbH
Germany
Vortrag
Empagliflozin reduces mortality and hospitalisation for heart failure in patients with or without a history of myocardial infarction or stroke at baseline
Speaker
Datum: 31.05.2019 , Zeit: 11:25
|
Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
Details